FRANCISCO JESÚS
FERNÁNDEZ-AVILÉS DÍAZ
Catedrático de universidad
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (32)
2023
-
Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 7
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
Journal of Clinical Medicine, Vol. 12, Núm. 8
2021
-
Ischemic etiology and prognosis in men and women with acute heart failure
Journal of Clinical Medicine, Vol. 10, Núm. 8
-
Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fraction
Internal Medicine Journal, Vol. 51, Núm. 6, pp. 930-938
-
Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain
REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178
2019
-
Cohort profile: Design and methods of the PREDIMED-Plus randomized trial
International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o
-
Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction
Internal Medicine Journal, Vol. 49, Núm. 12, pp. 1505-1513
2018
-
Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial
PLoS ONE, Vol. 13, Núm. 6
2017
-
Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
European Heart Journal, Vol. 38, Núm. 9, pp. 648-660
2016
-
Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention
Journal of the American College of Cardiology, Vol. 67, Núm. 23, pp. 2705-2715
-
Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)
American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584
2015
-
Temporal trends in the use of reperfusion therapy and outcomes in elderly patients with first ST elevation myocardial infarction
European heart journal. Acute cardiovascular care, Vol. 4, Núm. 5, pp. 461-467
2012
2009
-
Therapeutic strategies after coronary stenting in chronically anticoagulated patients: The MUSICA study
Heart, Vol. 95, Núm. 18, pp. 1483-1488
2007
-
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: Long-term results of the DIABETES trial
European Heart Journal, Vol. 28, Núm. 16, pp. 1946-1952
-
Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: The GRACIA-2 non-inferiority, randomized, controlled trial
European Heart Journal, Vol. 28, Núm. 8, pp. 949-960
-
Prognostic Stratification of Patients with Left-Sided Endocarditis Determined at Admission
American Journal of Medicine, Vol. 120, Núm. 4
2006
-
Eficacia de la implantación del stent recubierto de rapamicina en pacientes diabéticos con vasos muy pequeños (≤2,25 mm). Subanálisis del estudio DIABETES
Revista Espanola de Cardiologia, Vol. 59, Núm. 10, pp. 1000-1007
-
Vascular Effects of Sirolimus-Eluting Versus Bare-Metal Stents in Diabetic Patients. Three-Dimensional Ultrasound Results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial
Journal of the American College of Cardiology, Vol. 47, Núm. 11, pp. 2172-2179